Back to ALLIANCEBERNSTEIN L.P. ALLIANCEBERNSTEIN L.P.

SPRYSPRY
Showing 8 of 15 quarters

Position history for ALLIANCEBERNSTEIN L.P.ALLIANCEBERNSTEIN L.P.'s holdings in ARS PHARMACEUTICALS INC

ALLIANCEBERNSTEIN L.P. holds 59,490 shares of SPRY (ARS PHARMACEUTICALS INC), worth $477,705 as of 2026-Q2. The position was increased (+41.7% shares). SPRY represents 0.0% of ALLIANCEBERNSTEIN L.P.'s portfolio.

Current Value

$477,705

Current Shares

59,490

Total Value Change

-$590,365

Total Shares Change

-14,170

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
59,490
+41.7%
$477,7050.0%$8.01
32
2026-Q1
Decreased
41,980
-30.2%
$489,0670.0%$8.87
0
2025-Q4
Decreased
60,120
-97.7%
$700,3980.0%$11.64
0
2025-Q3
Decreased
2.6M
-30.9%
$26.6M0.0%$9.72
0
2025-Q2
Decreased
3.8M
-2.5%
$66.8M0.0%$18.20
0
2025-Q1
Increased
3.9M
+1.1%
$49.3M0.0%$12.49
30
2024-Q4
Increased
3.9M
+5168.4%
$40.9M0.0%$10.62
47
2024-Q3
Unchanged
73,660
0.0%
$1.1M0.0%$14.32
0

Other major holders of SPRY: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used